Breaking
πŸ‡ΊπŸ‡Έ FDA

Bio-IT World 2026: AI in Oncology Takes Center Stage

The Bio-IT World Conference & Expo 2026 will focus on AI applications in life sciences and includes a dedicated AI for Oncology track. The conference will be held in Boston from May 19-21, 2026, in a hybrid format.

Bio-IT World 2026: AI in Oncology Takes Center Stage

Key Takeaways

  • Bio-IT World Conference & Expo 2026 will focus on AI applications in life sciences.
  • The event includes a dedicated AI for Oncology track.
  • No specific oncology drug data or clinical trial results are expected to be presented.
  • The conference will be held in Boston from May 19-21, 2026, in a hybrid format.

The Bio-IT World Conference & Expo, a leading event for bioinformatics, IT, and data science professionals in the life sciences, will take place in Boston from May 19-21, 2026. The conference will explore the latest advancements in AI, data science, and other technologies impacting drug discovery and development. A dedicated "AI for Oncology" track will be featured.

The 25th Annual Bio-IT World Conference & Expo aims to connect biopharma, IT, and research professionals to discuss innovations in data science and AI. The hybrid event, held at the Omni Boston Hotel at the Seaport, will offer both in-person and virtual attendance options.

Conference Overview

The Bio-IT World Conference & Expo 2026 is scheduled for May 19–21, 2026, in Boston, focusing on life sciences, healthcare, biotech, informatics, precision medicine, AI, data analytics, and R&D workflows. The conference will be held in a hybrid format, offering both in-person and virtual attendance.

Key focus areas include:

  • AI applications in drug development
  • Data science innovations in pharma R&D workflows
  • Quantum computing for drug discovery

AI for Oncology Track

The conference will feature a dedicated AI for Oncology track. This track will cover the deployment of AI for cancer therapies. However, available sources do not list specific oncology drugs, International Nonproprietary Names (INN), clinical trial National Clinical Trial (NCT) numbers, or company drug pipelines.

Related Sessions

In addition to the AI for Oncology track, the conference will include related sessions such as:

  • A plenary session on federated learning for structural biology data sharing, featuring speakers from Columbia University, Eli Lilly, Apheris, Psivant Therapeutics, and Bayer.
  • The Bio-IT World FAIR Data Hackathon, which will include projects such as "Visible Neural Networks for Cancer Drug Response (CellMap-VNN)" and "Drug Repurposing via Disease Similarity and Biomarker Networks."
  • An Innovation Showcase featuring emerging AI companies for the life sciences, such as MadeAI and Redouble AI.

No Oncology Drugs Data Found

Current sources lack details on specific oncology drugs (INN), clinical trials (NCT), or company presentations with drug data. While Inductive Bio won a prediction competition, no specific oncology drug disclosures for 2026 have been announced.

Frequently Asked Questions

  • What is the Bio-IT World Conference & Expo 2026 about?

    It is a conference focusing on the applications of AI and data science in life sciences, drug discovery, and healthcare.

  • When and where will the conference take place?

    The conference will be held from May 19-21, 2026, in Boston, MA, at the Omni Boston Hotel at the Seaport.

  • Is there a specific focus on oncology?

    Yes, there is a dedicated "AI for Oncology" track at the conference.

  • Will there be presentations on specific oncology drugs or clinical trial data?

    Based on currently available information, no specific oncology drug data or clinical trial results are expected to be presented.

  • How can I attend the conference?

    The conference is a hybrid event, offering both in-person and virtual attendance options. Advance registration ends April 10, 2026.

References

  1. Rozie Synopsis: 10 Healthcare Conferences in 2026 Worth Adding to Your Calendar
  2. Intuition Labs: Conferences
  3. BioSpace Press Release: Impact Biotech Announces Upcoming Data Presentations for Padeliporfin VTP at AUA and ASCO 2026
  4. HealthTech.com
  5. Maat Pharma: Bio International Convention 2026
  6. ALMCORP: AI Conferences in May 2026
  7. Simons Foundation: National Institute for Theory and Mathematics in Biology Annual Meeting 2026

Related Articles

FDA Accelerated Approval Pathway: Impact on Oncology Market Access & Pricing in 2026
AnalysisMay 2, 2026

FDA Accelerated Approval Pathway: Impact on Oncology Market Access & Pricing in 2026

Oliver Grant
COFEPRIS Approval Pathway: Insights on Novel Immunotherapies for Advanced Melanoma
AnalysisMay 2, 2026

COFEPRIS Approval Pathway: Insights on Novel Immunotherapies for Advanced Melanoma

Dr. Elena Rossi
Cancer Immunotherapies UAE: Regulatory and Access Insights 2025
AnalysisMay 2, 2026

Cancer Immunotherapies UAE: Regulatory and Access Insights 2025

Oliver Grant
FDA Accelerated Approvals Oncology: 2026 Policy Review & Zongertinib Case
AnalysisApr 30, 2026

FDA Accelerated Approvals Oncology: 2026 Policy Review & Zongertinib Case

Dr. Priya Nandakumar